Source link : https://www.newshealth.biz/health-news/novel-score-predicts-weight-loss-with-semaglutide-in-t2d/
TOPLINE: Patients with both type 2 diabetes (T2D) and obesity, who have a lower diabetes severity, as characterized by the individualized metabolic surgery (IMS) scoring system, achieve better weight loss outcomes with semaglutide. METHODOLOGY: Prior studies indicate that semaglutide leads to inferior weight loss outcomes in patients with obesity who have T2D vs those without […]
Author : News Health
Publish date : 2024-05-30 11:59:04
Copyright for syndicated content belongs to the linked Source.
in Health